Literature DB >> 6507044

Demential syndromes and the lipid metabolism.

J Clausen.   

Abstract

The present communication surveys the present knowledge about the extent to which formation of free radicals in the central nervous system may give rise to cross-linking reactions finally ending in the deposition of lipofuscin pigments. Free radicals may be formed by autoperoxidation of polyunsaturated fatty acids. These fatty acids, e.g., C22:6 omega 3, are enriched in rods and cones of the eye and in phosphatidyl ethanolamine of synaptosomes. By peroxidation, malondialdehyde is formed. This aldehyde may cross-link through amino groups of proteins and certain phospholipids. Hereby, lipofuscin is deposited. The peroxidation process is counteracted by certain enzymic systems and by antioxidants. Thus, glutathionperoxidase (GSH-Px), catalase and superoxid dismutase may eliminate peroxides. GSH-Px is a selenium-containing enzyme. Peroxides are also formed by metabolic transformation of dopamine. 3 demential syndromes, i.e. Alzheimer's, Parkinson's and Batten's diseases, are discussed with regard to whether the "free radical theory" may explain the pathogenesis. Finally, it is discussed whether an antioxidative treatment including vitamins E and C as well as a supplement of selenium, e.g. sodiumselenite, may be a therapeutic alternative to other types of treatment of demential syndromes or a direct supplement to the L-DOPA treatment of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6507044     DOI: 10.1111/j.1600-0404.1984.tb00835.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  13 in total

Review 1.  Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids.

Authors:  A A Farooqui; L Liss; L A Horrocks
Journal:  Metab Brain Dis       Date:  1988-03       Impact factor: 3.584

2.  Fragmentation of a linoleate-derived γ-hydroperoxy-α,β-unsaturated epoxide to γ-hydroxy- and γ-oxo-alkenals involves a unique pseudo-symmetrical diepoxycarbinyl radical.

Authors:  Xiaodong Gu; Robert G Salomon
Journal:  Free Radic Biol Med       Date:  2011-12-01       Impact factor: 7.376

3.  Uptake and distribution in rat brain of organic and inorganic selenium.

Authors:  J Clausen
Journal:  Biol Trace Elem Res       Date:  1991-01       Impact factor: 3.738

4.  Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls.

Authors:  T Metcalfe; D M Bowen; D P Muller
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

5.  Early developmental exposure to benzodiazepine ligands alters brain levels of thiobarbituric acid-reactive products in young adult rats.

Authors:  R C Miranda; J P Wagner; C K Kellogg
Journal:  Neurochem Res       Date:  1989-11       Impact factor: 3.996

6.  Effects of low selenium diets on antioxidant status and MPTP toxicity in mice.

Authors:  M S Sutphin; T D Buckman
Journal:  Neurochem Res       Date:  1991-12       Impact factor: 3.996

7.  The uptake of Na-selenite in rat brain. Localization of new glutathione peroxidases in the rat brain.

Authors:  K Huang; E Lauridsen; J Clausen
Journal:  Biol Trace Elem Res       Date:  1994 Oct-Nov       Impact factor: 3.738

8.  Biochemical and clinical effects of an antioxidative supplementation of geriatric patients. A double blind study.

Authors:  J Clausen; S A Nielsen; M Kristensen
Journal:  Biol Trace Elem Res       Date:  1989 Apr-May       Impact factor: 3.738

9.  Selenium in chronic neurologic diseases. Multiple sclerosis and Batten's disease.

Authors:  J Clausen; G E Jensen; S A Nielsen
Journal:  Biol Trace Elem Res       Date:  1988 Jan-Apr       Impact factor: 3.738

Review 10.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.